Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Chad Robins

Chad Robins is recorded as CEO and Board Member at Adaptive Biotechnologies Corp (ADPT). The proxy statement of Adaptive Biotechnologies Corp reports total compensation of $9,081,690 for Chad Robins in fiscal 2025, including a base salary of $698,258. Disclosed compensation is on record for 6 fiscal years. Chad Robins has spoken on 26 earnings calls and 1 other investor event across 1 company, most recently for Adaptive Biotechnologies Corp on July 29, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Adaptive Biotechnologies Corp

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Adaptive Biotechnologies Corp (ADPT) $698,258 $9,081,690
2024 Adaptive Biotechnologies Corp (ADPT) $677,918 $4,973,301
2023 Adaptive Biotechnologies Corp (ADPT) $663,000 $8,904,267
2022 Adaptive Biotechnologies Corp (ADPT) $658,188 $8,853,328
2021 Adaptive Biotechnologies Corp (ADPT) $639,063 $8,751,617
2020 Adaptive Biotechnologies Corp (ADPT) $597,400 $7,131,118

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 15 earlier activities